Project Grant R01MD021645
- The National Institute for Minority Health and Health Disparities awarded Texas A&M Agrilife Research $772,567 on June 21, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a multi-site, church-engaged randomized trial reducing cardiovascular disease and cancer risk in lower-income communities across the Dallas-Fort Worth metroplex. The project, "StrongPeople Together," engages ten church sites through three coordinated aims. Aim 1...
- The National Institute for Minority Health and Health Disparities awarded The University of Texas Southwestern Medical Center $1.347 million on July 18, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to test the efficacy of a family-level hypertension self-management intervention for African American primary care patients. The project, titled "WALK TOGETHER Trial," will conduct a randomized controlled study of a novel dyadic intervention delivered...
- The National Institute on Aging awarded The University of Texas Southwestern Medical Center $799,870 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a randomized controlled trial testing a multi-dimensional tailored telehealth intervention for heart failure with preserved ejection fraction in older adults. The intervention integrates physical rehabilitation targeting strength, balance, mobility, and endurance with health coaching addressing emotional regulation...
- The National Institute for Minority Health and Health Disparities awarded Sam Houston State University $218,160 under the Minority Health and Health Disparities Research program (CFDA 93.307) on September 1, 2026. The award funds research to optimize mobile health clinic utilization and resource allocation in rural southwest Oklahoma. The project pursues two primary aims: identifying barriers to mobile health clinic uptake among rural residents, healthcare providers, and clinic staff through...
- The National Institute for Minority Health and Health Disparities awarded Brown University $755,110 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a mixed-methods study examining the implications of Medicare Advantage enrollment growth on mortality and clinical outcomes among older adults in rural America. The research investigates how Medicare Advantage provider networks and reimbursement practices affect access to acute hospital...
- The National Institute for Minority Health and Health Disparities awarded the University of Texas at Arlington $1,316,481 under the Minority Health and Health Disparities Research program (CFDA 93.307) on June 29, 2026. The project develops a measurement instrument to assess daily experiences of social stress and their immediate psychological and behavioral effects, and investigates associations between stress-related daily social experiences and risks of hypertension and cardiovascular disease....
- The National Institute for Minority Health and Health Disparities awarded Duke University $771,059 on August 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and test a tailored mHealth coaching and social resource support intervention designed to improve medication adherence and patient activation among kidney transplant recipients in low-resource communities. The project addresses health disparities in post-transplant outcomes, where...
- The National Institute for Minority Health and Health Disparities awarded Massachusetts Eye and Ear Infirmary $1,009,557 on August 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a multi-level technology-enabled intervention study comparing hybrid telemedical visits and in-person visits for managing diabetic retinopathy. The recipient will conduct a single-institution, block-stratified randomized prospective clinical trial enrolling 472...
- The National Institute for Minority Health and Health Disparities awarded the University of Alabama at Birmingham $363,573 on July 18, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307, Project Grant R21MD020868) to develop a provider-to-provider teletrauma implementation toolkit for rural emergency departments. The toolkit will guide sustainable deployment of telehealth-enabled trauma care consultation in rural settings, enabling injured patients at rural...
- The National Heart, Lung, and Blood Institute awarded the University of Texas Southwestern Medical Center $811,633 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of endotrophin in heart failure with preserved ejection fraction. The recipient will conduct basic and translational research examining endotrophin (ETP), a bioactive cleavage product of collagen VI, as a molecular driver of heart failure with preserved ejection fraction...
The National Institute for Minority Health and Health Disparities awarded The University of Texas Southwestern Medical Center $834,657 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a randomized controlled trial evaluating telemedicine-enabled guideline-directed medical therapy optimization for rural heart failure patients. The Rural-HF Trial is a Type 1 hybrid effectiveness-implementation study enrolling 600 patients hospitalized with acute heart failure at rural hospitals across two health systems. The intervention employs provider-to-provider telehealth collaboration, in which cardiovascular specialists provide evidence-based, protocol-driven guideline-directed medical therapy initiation and uptitration recommendations to participants' outpatient care teams. The study team reviews physiologic data—blood pressure, heart rate, and weight transmitted from cellular-enabled remote monitoring devices—weekly and provides specific medication recommendations at weekly intervals during the first six weeks post-discharge, without requiring home internet access. The trial addresses a documented gap: rural heart failure patients face approximately 20 percent higher mortality risk than urban counterparts, driven largely by poor access to cardiology specialty care and underutilization of guideline-directed medical therapy, which accounts for an estimated 16 percent of excess mortality risk. Performance occurs at Dallas, Texas. The period of performance runs from September 1, 2026, through March 31, 2031. This is a Project Grant assistance type award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $834.7k | 9/1/26 |